- Companies
- Tarsier Pharma
Tarsier Pharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for Tarsier Pharma.
Tarsier Pharma Overview
About Tarsier Pharma
Tarsier Pharma Ltd is a late clinical stage biopharmaceutical company, focused on the development and commercialization of novel pharmaceutical therapies to address unmet needs in ocular diseases with underlying inflammatory pathologies. Its dazdotuftide platform technology is a bio-inspired immunomodulator designed to treat blinding inflammatory ocular diseases, and is currently being developed as both eye drops and intravitreal injections. The company's Product Candidate Pipeline includes TRS01 and TRS02.
Founded
2016
HQ
Employees
7
Website
Sectors
Financials (Last FY)
Market Cap
-
Valuation Multiples
Start free trialTarsier Pharma Stock Performance
Tarsier Pharma has current market cap of -.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTarsier Pharma Valuation Multiples
Tarsier Pharma Financial Valuation Multiples
As of November 19, 2026, Tarsier Pharma has market cap of -.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Tarsier Pharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Tarsier Pharma Competitors
Tarsier Pharma competitors include Eli Lilly, Johnson & Johnson, AbbVie, Roche, Merck, Novartis, AstraZeneca, Amgen, Gilead Sciences and Novo Nordisk.
Most Tarsier Pharma public comparables operate across Biopharmaceuticals and BioTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $65B | $28B | 19.6x | 14.5x | 46.0x | 30.5x | |||
| $94B | $40B | 7.3x | 6.8x | 17.1x | 18.5x | |||
| $61B | $17B | 9.4x | 8.6x | 33.2x | 18.2x | |||
| $75B | $26B | 5.5x | 5.4x | 16.2x | 13.7x | |||
| $65B | $28B | 5.9x | 5.7x | 13.7x | 22.2x | |||
| $57B | $22B | 5.9x | 5.9x | 15.3x | 14.3x | |||
| $59B | $19B | 5.3x | 5.0x | 16.1x | 13.8x | |||
| $37B | $17B | 7.6x | 7.2x | 16.7x | 15.9x | |||
This data is available for Pro users. Sign up to see all Tarsier Pharma competitors and their valuation data. Start Free Trial | ||||||||
Tarsier Pharma VC Funding History
Before going public, Tarsier Pharma raised $3M in total equity funding, across 1 round.
Last private valuation of Tarsier Pharma was $16M, after raising $3M in September 2018 from Sun Pharma.
Tarsier Pharma Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Tarsier Pharma
| When was Tarsier Pharma founded? | Tarsier Pharma was founded in 2016. |
| Where is Tarsier Pharma headquartered? | Tarsier Pharma is headquartered in Israel. |
| How many employees does Tarsier Pharma have? | As of today, Tarsier Pharma has over 7 employees. |
| Is Tarsier Pharma publicly listed? | Yes, Tarsier Pharma is a public company listed on NYSE. |
| What is the stock symbol of Tarsier Pharma? | Tarsier Pharma trades under TARX ticker. |
| When did Tarsier Pharma go public? | Tarsier Pharma went public in 2050. |
| Who are competitors of Tarsier Pharma? | Tarsier Pharma main competitors include Eli Lilly, Johnson & Johnson, AbbVie, Roche, Merck, Novartis, AstraZeneca, Amgen, Gilead Sciences, Novo Nordisk. |
| Is Tarsier Pharma profitable? | No, Tarsier Pharma is not profitable. |
| How many companies Tarsier Pharma has acquired to date? | Tarsier Pharma hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Tarsier Pharma has invested to date? | Tarsier Pharma hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Tarsier Pharma
Lists including Tarsier Pharma
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




